Her research emphasis is on exploring novel rational treatment options to enhance therapeutic efficacy and personalized medicine in interdisciplinary, translational research. This has led to research regarding pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases, early clinical trials with novel anticancer agents, as well as large scale registration and translational trials for rare subgroups including male and inflammatory breast cancer. It has also led to preclinical and clinical molecular imaging studies, with regard to visualization of tumor specific targets, particularly regarding the estrogen and androgen receptors.